openPR Logo
Press release

Carglumic Acid Market, Scenario Highlighting Growth and Major Drivers by 2021-2027

08-15-2023 09:44 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Carglumic Acid Market, Scenario Highlighting Growth and Major

Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033.

The global pharmaceutical and healthcare industry is characterized by constant innovation and the development of new treatment options. One such innovative product that has gained attention in recent years is Carglumic Acid, a medication used in the treatment of a rare metabolic disorder known as N-acetylglutamate synthase (NAGS) deficiency.
This disorder, though rare, can have severe consequences for patients if left untreated, making Carglumic Acid a crucial therapeutic option. In this article, we will delve into the Carglumic Acid market, its applications, key players, market trends, and future prospects.

Get a FREE Sample Copy of the Report (Including TOC, List of Tables & Figures, and Chart):https://www.factmr.com/connectus/sample?flag=S&rep_id=7068?AG

Understanding Carglumic Acid:

Carglumic Acid, also known by its trade name Carbaglu®, is a synthetic medication that acts as a carbamoyl phosphate synthetase 1 (CPS1) activator. It plays a pivotal role in the urea cycle, a metabolic pathway that helps eliminate excess nitrogen from the body. NAGS deficiency, a genetic disorder, impairs the urea cycle, leading to the accumulation of ammonia in the blood, which can result in serious health complications, including neurological damage and organ failure. Carglumic Acid addresses this deficiency by facilitating ammonia detoxification and promoting the proper functioning of the urea cycle.

Market Dynamics and Key Players:

The Carglumic Acid market is relatively niche due to the rarity of NAGS deficiency. However, its importance in managing this life-threatening condition has positioned it as an essential drug within the orphan drug category. Orphan drugs are medications developed to treat rare diseases, offering a unique market dynamic with a focus on patient needs rather than sheer commercial profit.

The market for Carglumic Acid is dominated by a few key players who have pioneered its research, development, and distribution. Companies like Orphan Europe (part of Recordati Rare Diseases) and SOBI (Swedish Orphan Biovitrum) have played instrumental roles in making Carglumic Acid accessible to patients across the globe. Their efforts not only involve drug production but also encompass patient education, advocacy, and support networks.

Market Trends and Challenges:

The Carglumic Acid market has witnessed steady growth over the years, primarily driven by increased awareness, improved diagnosis of NAGS deficiency, and advancements in medical infrastructure. Additionally, regulatory incentives and expedited approval processes for orphan drugs have contributed to the market's expansion.

However, the market is not without its challenges. One of the primary obstacles is the limited patient pool due to the rarity of NAGS deficiency. This has implications for research funding, clinical trials, and overall market viability. The high cost of orphan drugs, including Carglumic Acid, also presents a challenge for both patients and healthcare systems. Striking a balance between accessibility and sustainability remains a critical consideration.

Future Prospects:

The future of the Carglumic Acid market holds promise, driven by evolving healthcare landscapes, increasing disease awareness, and ongoing research. As precision medicine gains prominence, personalized treatment approaches could lead to tailored interventions for NAGS deficiency patients, optimizing therapeutic outcomes.

Continued research into the broader potential applications of Carglumic Acid beyond NAGS deficiency could also open up new avenues for market expansion. Exploring its utility in related metabolic disorders or as an adjunct therapy in certain cases might broaden its reach.

Moreover, collaborations between pharmaceutical companies, research institutions, and patient advocacy groups will play a crucial role in shaping the market's trajectory. These collaborations can facilitate information exchange, promote research initiatives, and drive the development of more affordable treatment options.

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7068?AG

Conclusion

the Carglumic Acid market, though niche, occupies a vital place in the pharmaceutical landscape. Its role in treating NAGS deficiency underscores the importance of addressing rare diseases and developing targeted therapies. While challenges exist, the market's future holds promise, driven by ongoing research, increasing awareness, and collaborative efforts across stakeholders. As the healthcare industry continues to prioritize patient-centric approaches, the Carglumic Acid market exemplifies the potential of innovation to make a profound impact on individuals' lives.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Us -
Fact.MR addresses this challenge head-on by providing insights (not data) that are easy to understand and execute. A leading provider of syndicated and custom market research reports, we offer cutting-edge business intelligence to clients from a range of industries.Our research team is highly qualified to help organizations with their market research needs. In a world where constant disruption is the norm rather than the exception, Fact.MR identifies opportunities and challenges early, and provides its clients the foundation for a winning strategy.We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carglumic Acid Market, Scenario Highlighting Growth and Major Drivers by 2021-2027 here

News-ID: 3165271 • Views:

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced

All 5 Releases


More Releases for Carglumic

Carglumic Acid Market is Expanding Rapidly with Promising Growth Prospects
Carglumic Acid Market latest research report added by USD Analytics. The Carglumic Acid Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in the future.
Carglumic Acid Market to Witness Huge Growth by 2028
Carglumic Acid market research report assists different industries to understand customer behavior towards particular product or service launch. It carries out detailed research and provides important market data about consumers. It assists different industries to formulate different strategies for expansion of business and increase the product portfolio in the marketplace. It aims at offering valuable market data to make effective decision. All the significant data provided here covers prediction of
Carglumic Acid Market Analysis, Status and Business Outlook 2017 to 2026
The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research (TMR). Carglumic acid is used to manufacture several forms of therapeutic tablets, and this is a key standpoint from the perspective of market growth. Read Report Overview - https://www.transparencymarketresearch.com/carglumic-acid-market.html The leading vendors in the global carglumic acid market have set on a spree to tie up with new
Carglumic Acid Market Analysis, Applications, Sale, Growth Insight, Trends By 20 …
LOS ANGELES, UNITED STATE: – The report on the global Carglumic Acid market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global  Carglumic Acid Market. It offers a detailed analysis of the competition and leading companies of
Carglumic Acid Market Witness Widespread Expansion by 2026
Transparency Market Research (TMR) has compiled a new comprehensive report on the global carglumic acid market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data
Carglumic Acid Market Companies Overview 2017 - 2026
The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research (TMR). Carglumic acid is used to manufacture several forms of therapeutic tablets, and this is a key standpoint from the perspective of market growth. The leading vendors in the global carglumic acid market have set on a spree to tie up with new selling points for